Logo image of PCLA

PICOCELA INC (PCLA) Stock Fundamental Analysis

NASDAQ:PCLA - US71989C1099 - ADR

0.4859 USD
+0.04 (+10.16%)
Last: 9/10/2025, 11:16:45 AM
Fundamental Rating

1

Overall PCLA gets a fundamental rating of 1 out of 10. We evaluated PCLA against 48 industry peers in the Communications Equipment industry. PCLA has a bad profitability rating. Also its financial health evaluation is rather negative. PCLA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PCLA had negative earnings in the past year.
PCLA had a negative operating cash flow in the past year.
PCLA Yearly Net Income VS EBIT VS OCF VS FCFPCLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -38.87%, PCLA is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
With a Return On Equity value of -135.27%, PCLA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -38.87%
ROE -135.27%
ROIC N/A
ROA(3y)-31.59%
ROA(5y)N/A
ROE(3y)-75.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCLA Yearly ROA, ROE, ROICPCLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 53.95%, PCLA is in the better half of the industry, outperforming 72.92% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for PCLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCLA Yearly Profit, Operating, Gross MarginsPCLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

PCLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PCLA has a worse debt to assets ratio.
PCLA Yearly Total Debt VS Total AssetsPCLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PCLA has an Altman-Z score of -1.09. This is a bad value and indicates that PCLA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PCLA (-1.09) is worse than 70.83% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that PCLA is somewhat dependend on debt financing.
The Debt to Equity ratio of PCLA (0.93) is worse than 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Altman-Z -1.09
ROIC/WACCN/A
WACC1.66%
PCLA Yearly LT Debt VS Equity VS FCFPCLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M

2.3 Liquidity

A Current Ratio of 2.18 indicates that PCLA has no problem at all paying its short term obligations.
PCLA has a Current ratio of 2.18. This is in the better half of the industry: PCLA outperforms 62.50% of its industry peers.
PCLA has a Quick Ratio of 1.70. This is a normal value and indicates that PCLA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.70, PCLA is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.18
Quick Ratio 1.7
PCLA Yearly Current Assets VS Current LiabilitesPCLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

1

3. Growth

3.1 Past

The earnings per share for PCLA have decreased strongly by -73.21% in the last year.
PCLA shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.19%.
EPS 1Y (TTM)-73.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.21%
Revenue 1Y (TTM)40.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%40.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCLA Yearly Revenue VS EstimatesPCLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200M 400M 600M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCLA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCLA Price Earnings VS Forward Price EarningsPCLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCLA Per share dataPCLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PCLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PICOCELA INC

NASDAQ:PCLA (9/10/2025, 11:16:45 AM)

0.4859

+0.04 (+10.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.76%
Inst Owner Change10.83%
Ins Owners12.38%
Ins Owner ChangeN/A
Market Cap16.19M
AnalystsN/A
Price TargetN/A
Short Float %0.91%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.03
P/FCF N/A
P/OCF N/A
P/B 6.7
P/tB 7.39
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.16
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.87%
ROE -135.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.95%
FCFM N/A
ROA(3y)-31.59%
ROA(5y)N/A
ROE(3y)-75.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 213.01%
Cap/Sales 5.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.18
Quick Ratio 1.7
Altman-Z -1.09
F-Score4
WACC1.66%
ROIC/WACCN/A
Cap/Depr(3y)189.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%40.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.18%
OCF growth 3YN/A
OCF growth 5YN/A